RESUMEN
Stimulus-responsive drug-loaded poly (N-isopropylacrylamide) nanogels were examined as a means of enhancing the delivery of naproxen into skin ex vivo. Following massaging into skin, the epidermis was probed (with and without base activation) for depth penetration and transdermal delivery of drug, and anti-inflammatory activity in the relative levels of COX-2 expression. Rat paw oedema testing was used to determine anti-inflammatory effects in vivo. When activated by sodium carbonate, particle size reduced by 19%. Tape stripping revealed significantly greater delivery of naproxen into the epidermis for the activated nanogel and the steady state flux was enhanced 2.8-fold. With base-activation COX-2 was 50% lower than non-activated, and this trend was confirmed by immunostaining, and by the reduction of rat paw swelling which provided ex vivo - in vivo corroboration. A mechanism of action is proposed. In conclusion, stimulus-responsive nanogels have potential for enhancing dermal drug delivery and therapeutic outcomes in inflammatory skin diseases.
Asunto(s)
Acrilamidas/química , Ciclooxigenasa 2/metabolismo , Sistemas de Liberación de Medicamentos , Edema/tratamiento farmacológico , Epidermis/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Naproxeno/administración & dosificación , Piel/efectos de los fármacos , Administración Cutánea , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Carragenina/toxicidad , Ciclooxigenasa 2/genética , Edema/inducido químicamente , Células Epidérmicas , Epidermis/metabolismo , Masculino , Nanogeles , Naproxeno/química , Naproxeno/farmacología , Polietilenglicoles/administración & dosificación , Polietilenglicoles/química , Polietileneimina/administración & dosificación , Polietileneimina/química , Polímeros/química , Ratas , Ratas Wistar , Piel/citología , Piel/metabolismoRESUMEN
The ease of application and no requirement of extra energy input make the microemulsion method favorable for solid lipid nanoparticles (SLNs) production. Very limited data are available to date on preparation of SLNs from pre-screened microemulsion phase diagrams. The purpose of this study was to investigate the microemulsion formation area with solid lipids using hot ternary phase diagrams at elevated temperatures and to use selected microemulsions for SLN production. Also, we aimed to characterize obtained SLNs in terms of physicochemical properties, in vitro cell toxicity, and hemolysis. Phase diagrams of solid lipids were screened at elevated temperatures and oil-in-water microemulsion regions were determined. Microemulsions were selected, and SLNs were produced by modification of the microemulsion dilution method and characterized in terms of visual appearance, turbidity, particle size, and zeta potential. Cytotoxicity of nanoparticles was tested on L929 mouse skin fibroblast cells. Hemolytic potential was assessed in vitro using freshly isolated erythrocytes. The phase diagram screening and the modified hot microemulsion dilution method enabled production of SLNs with particle size below 100 nm. We found evidence that the solid lipids in the SLNs produced by the new method remain in supercooled liquid state. Nanoparticles prepared by the new method exhibit lower toxicity on L929 cells and have lower hemolytic potential than the formulations prepared by direct mixing of the components. The method can be used to prepare SLNs with controllable composition and small particle size below 100 nm. These SLNs are low toxic and can be used for drug delivery purposes.
Asunto(s)
Sistemas de Liberación de Medicamentos , Lípidos/química , Nanopartículas/química , Animales , Emulsiones , Hemólisis/efectos de los fármacos , Ratones , Nanopartículas/toxicidad , Tamaño de la Partícula , Tecnología FarmacéuticaRESUMEN
The objective of this study is to develop a new textile-based drug delivery system containing naproxen (NAP) microparticles and to evaluate the potential of the system as the carrier of NAP for topical delivery. Microparticles were prepared by spray-drying using an aqueous ethyl cellulose dispersion. The drug content and entrapment efficiency, particle size and distribution, particle morphology and in vitro drug release characteristics of microparticles were optimized for the application of microparticles onto the textile fabrics. Microparticles had spherical shape in the range of 10-15 µm and a narrow particle size distribution. NAP encapsulated in microparticles was in the amorphous or partially crystalline nature. Microparticles were tightly fixed onto the textile fabrics. In vitro drug release exhibited biphasic release profile with an initial burst followed by a very slow release. Skin permeation profiles were observed to follow near zero-order release kinetics.
Asunto(s)
Antiinflamatorios no Esteroideos , Celulosa/análogos & derivados , Sistemas de Liberación de Medicamentos , Naproxeno , Textiles , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacocinética , Antiinflamatorios no Esteroideos/farmacología , Celulosa/química , Masculino , Naproxeno/química , Naproxeno/farmacocinética , Naproxeno/farmacología , Ratas , Ratas WistarRESUMEN
The main objective of this study was to investigate the release and pharmacokinetic profiles of ketoprofen (KP) from developed thermosensitive and mucoadhesive liquid suppositories. Thermosensitive liquid suppositories were prepared using KP, poloxamer 407 (P 407), poloxamer 188 (P 188) and various amounts of different mucoadhesive polymers. In vitro release studies was monitored by the USP XXVI paddle method. The results thus obtained were evaluated kinetically and mechanism of release was analyzed. Identification of poloxamer gel localization in vivo was conducted using white male rabbits by adding 1 % methylene blue. For in vivo studies, twenty-four white male rabbits were randomly divided into three groups. The rabbits in each group were administered with liquid suppository F1 [P407/P188/KP (4/20/2.5 %)], F5 [P407/P188/KP/C (4/20/2.5/0.8 %)] or conventional suppository (F-C) into the rectum. The plasma concentration of KP was analyzed by high performance liquid chromatography (HPLC). C max, AUC, MRT and T max were evaluated. The release of KP was variously affected by the mucoadhesive polymers. In vitro release studies showed that Carbopol 934 P(C) has significant effect on release rate among the mucoadhesive polymers. When the formulations were evaluated kinetically, different kinetic models were obtained. Formulation F6 [P407/P188/KP/C (4/20/2.5/1.6 %)] which contains the highest C concentration and very high viscosity, shows a significantly better fit with Higuchi kinetic model. n value of this formulation was also found approximately 0.5. n exponent results of the other formulations showed that KP might be released from the suppositories by non-Fickian diffusion. Identification of poloxamer gel localization in vivo showed that the suppositories remain in the rectum without leakage after administration. With regard to the results of in vivo studies, the AUC6â14 values of KP in liquid suppository containing C are significantly higher than those in liquid suppository without C. MRT0â24 and MRT0â∞ values of liquid suppository containing C are significantly higher than those in liquid suppository without C and conventional suppository. Conventional suppository and liquid suppository without C significantly gave faster time to reach the maximum plasma concentrations of KP. With regard to the in vitro and in vivo experiments, liquid suppository formulation F5 might be a promising formulation for the development of an effective rectal dosage form.
Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Cetoprofeno/administración & dosificación , Animales , Área Bajo la Curva , Geles , Cetoprofeno/química , Cetoprofeno/farmacocinética , Masculino , Conejos , Solubilidad , Supositorios/administración & dosificaciónRESUMEN
The aim of the study was to accelerate the dissolution of the sustained release dosage forms using both elevated temperature and high rpm rates. Teokap(®) SR 200 mg pellets were tested by in vitro sustained and accelerated dissolution studies using USP XXIII rotating paddle method. Sustained dissolution studies were carried out for 12 h in phosphate buffer at 37 ± 0.5°C and 50 rpm. Accelerated dissolution studies were performed for 48 min in distilled water at 90 ± 1°C and 250 rpm. The results obtained from accelerated and sustained dissolution studies were correlated using both linear and linear kinetic correlation methods by a computer program. While r (2) and maximum error between calculated and observed drug release rates were found to be 0.9129 and 15.9%, respectively, in linear correlation method, these values were observed as 0.9938 and 3.6%, respectively, in linear kinetic correlation method. In vivo plasma concentration data were obtained from six New Zealand rabbits after administration of a single dose of Teokap(®) SR 200 mg pellet. Then, the results of in vivo study were evaluated with in vitro accelerated and sustained dissolution results by applying them to in vitro-in vivo linear correlations. As a result of these correlations, it was shown that the in vitro correlation plots were very similar to the plot which was obtained by the in vivo study (f (2) = 73.81-77.11). This study suggested a way to prevent the loss of time for routine dissolution studies of sustained release preparations for quality control procedures using in vitro accelerated dissolution tests. The storage and quarantine periods of the product in process and process controls in the manufactories could be shortened by this method. Calculation of the in vivo performance of sustained release dosage forms using the results of the accelerated dissolution studies may be counted as another advantage of the method.
Asunto(s)
Teofilina/administración & dosificación , Animales , Preparaciones de Acción Retardada , Masculino , Conejos , Solubilidad , Teofilina/químicaRESUMEN
This study developed and examined the characterization of Benzidamine hydrochloride (BNZ) bioadhesive gels as platforms for oral ulcer treatments. Bioadhesive gels were prepared with four different hydroxypropylmethylcellulose (HPMC) types (E5, E15, E50 and K100M) with different ratios. Each formulation was characterized in terms of drug release, rheological, mechanical properties and adhesion to a buccal bovine mucosa. Drug release was significantly decreased as the concentration and individual viscosity of each polymeric component increased due to improved viscosity of the gel formulations. The amount of drug released for the formulations ranged from 0.76 +/- 0.07 and 1.14 +/- 0.01 (mg/cm2 +/- SD). Formulations exhibited pseudoplastic flow and all formulations, increasing the concentration of HPMC content significantly raised storage modulus (G'), loss modulus (G''), dynamic viscosity (eta') at 37 degrees C. Increasing concentration of each polymeric component also significantly improved the hardness, compressibility, adhesiveness, cohesiveness and mucoadhesion but decreased the elasticity of the gel formulations. All formulations showed non-Fickian diffusion due to the relaxation and swelling of the polymers with water. In conclusion, the formulations studied showed a wide range of mechanical and drug diffusion characteristics. On the basis of the obtained data, the bioadhesive gel formulation which was prepared with 2.5% HPMC K 100M was determined as the most appropriate formulation for buccal application in means of possessing suitable mechanical properties, exhibiting high cohesion and bioadhesion.
Asunto(s)
Bencidamina/administración & dosificación , Sistemas de Liberación de Medicamentos , Fenómenos Mecánicos , Úlceras Bucales/tratamiento farmacológico , Reología , Adhesividad , Administración Bucal , Animales , Bencidamina/química , Bencidamina/farmacocinética , Disponibilidad Biológica , Bovinos , Fuerza Compresiva , Elasticidad , Geles/química , Dureza , Humanos , Derivados de la Hipromelosa , Metilcelulosa/análogos & derivados , Metilcelulosa/química , Mucosa Bucal/química , Parabenos/química , Sustancias Viscoelásticas/químicaRESUMEN
The purpose of this research was to develop an emulsion formulation of indomethacin (IND) suitable for nasal delivery. IND was incorporated into the oil phases of oil in water (O/W) and water in oil (W/O) emulsions. For this purpose, different emulsifying agents (Tween 80, Span 80 and Brij 58) were used in two emulsion formulations. When the effects of several synthetic membranes (nylon, cellulose, cellulose nitrate) were compared with the sheep nasal mucosa, the cellulose membrane and sheep nasal mucosa showed similar permeation properties for O/W emulsion (P > 0.05). To examine the absorption characteristics of IND, the anti-inflammatory properties of intravenous solution of IND, intranasal O/W emulsions of IND (with or without enhancers) and intranasal solution of IND (IND-Sol) were investigated in rats with carrageenan-induced paw edema. When citric acid was added to the nasal emulsion, the anti-inflammatory activity was similar to that of intravenous solution (P > 0.05). Finally, it was concluded that, intranasal administration of IND emulsion with citric acid may be considered as an alternative to intravenous and per oral administrations of IND to overcome their adverse effects.
Asunto(s)
Antiinflamatorios no Esteroideos/administración & dosificación , Edema/prevención & control , Indometacina/administración & dosificación , Mucosa Nasal/metabolismo , Aceite de Soja/química , Agua/química , Administración Intranasal , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/metabolismo , Carragenina , Cetomacrogol/química , Química Farmacéutica , Ácido Cítrico/química , Modelos Animales de Enfermedad , Composición de Medicamentos , Edema/inducido químicamente , Emulsionantes/química , Emulsiones , Hexosas/química , Indometacina/química , Indometacina/metabolismo , Inyecciones Intravenosas , Masculino , Membranas Artificiales , Permeabilidad , Polisorbatos/química , Ratas , Ratas Wistar , Ovinos , Factores de TiempoRESUMEN
In this study, the first aim was to investigate the swelling and relaxation properties of lipid matrix on diffusional exponent (n). The second aim was to determine the desired release profile of metronidazole lipid matrix tablets. We prepared metronidazole lipid matrix granules using Carnauba wax, Beeswax, Stearic acid, Cutina HR, Precirol ATO 5, and Compritol ATO 888 by hot fusion method and pressed the tablets of these granules. In vitro release test was performed using a standard USP dissolution apparatus I (basket method) with a stirring rate of 100 rpm at 37 degrees C in 900 ml of 0.1 N hydrochloric acid, adjusted to pH 1.2, as medium for the formulations' screening. Hardness, diameter-height ratio, friability, and swelling ratio were determined. Target release profile of metronidazole was also drawn. Stearic acid showed the highest and Carnauba wax showed the lowest release rates in all formulations used. Swelling ratios were calculated after the dissolution of tablets as 9.24%, 6.03%, 1.74%, and 1.07% for Cutina HR, Beeswax, Precirol ATO 5, and Compritol ATO 888, respectively. There was erosion in Stearic acid, but neither erosion nor swelling in Carnauba wax, was detected. According to the power law analysis, the diffusion mechanism was expressed as pure Fickian for Stearic acid and Carnauba wax and the coupling of Fickian and relaxation contributions for other Cutina HR, Beeswax, Compritol ATO 888, and Precirol ATO 5 tablets. It was found that Beeswax (kd=2.13) has a very close drug release rate with the target profile (kt=1.95). Our results suggested that swelling and relaxation properties of lipid matrices should be examined together for a correct evaluation on drug diffusion mechanism of insoluble matrices.
Asunto(s)
Lípidos/química , Metronidazol/administración & dosificación , Química Farmacéutica , Preparaciones de Acción Retardada , Difusión , Lípidos/administración & dosificación , Metronidazol/química , Tamaño de la Partícula , Solubilidad , Comprimidos , Ceras/químicaRESUMEN
The aim of this study was to evaluate and compare the in vitro and in vivo transdermal potential of w/o microemulsion (M) and gel (G) bases for diclofenac sodium (DS). The effect of dimethyl sulfoxide (DMSO) as a penetration enhancer was also examined when it was added to the M formulation. To study the in vitro potential of these formulations, permeation studies were performed with Franz diffusion cells using excised dorsal rat skin. To investigate their in vivo performance, a carrageenan-induced rat paw edema model was used. The commercial formulation of DS (C) was used as a reference formulation. The results of the in vitro permeation studies and the paw edema tests were analyzed by repeated-measures analysis of variance. The in vitro permeation studies found that M was superior to G and C and that adding DMSO to M increased the permeation rate. The permeability coefficients (Kp) of DS from M and M+DMSO were higher (Kp = 4.9 x 10(-3) +/- 3.6 x 10(-4) cm/h and 5.3 x 10(-3) +/- 1.2 x 10(-3) cm/h, respectively) than the Kp of DS from C (Kp = 2.7 x 10(-3) +/- 7.3 x 10(-4) cm/h) and G (Kp = 4.5 x 10(-3) +/- 4.5 x 10(-5) cm/h). In the paw edema test, M showed the best permeation and effectiveness, and M+DMSO had nearly the same effect as M. The in vitro and in vivo studies showed that M could be a new, alternative dosage form for effective therapy.
Asunto(s)
Diclofenaco/administración & dosificación , Diclofenaco/química , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Composición de Medicamentos/métodos , Excipientes/química , Piel/química , Absorción , Administración Cutánea , Animales , Difusión , Técnicas In Vitro , Masculino , Ensayo de Materiales , Ratas , Absorción CutáneaRESUMEN
The sentinel lymph node (SLN) is defined as the first regional lymph node to receive lymphatic drainage from a malignant tumor. Therefore, this node is a "sentinel" for second metastatic lymph node stations and for labeling regional tumor spread. For SLN detection, many surgeons preferred a combination of a preoperative injection of radiolabeled colloid and the intraoperative injection of blue dye. Under this combination protocol, nodes are considered to be "sentinel nodes" if they are radioactive and blue. The aim of this study is to develop a new single agent that combines both detection methods. For this purpose Isosulfan Blue (ISB) was radiolabeled by 99mTc with high labeling yield and stability. In vivo gamma scintigraphy studies were performed with rats. According to the scintigraphic studies, 99mTc-ISB shows rapid and high accumulation in both axillary (ALN) and popliteal lymph node (PLN). After the imaging study, extremity was opened and nodes were scanned for the radioactivity. According to performed study the lymph nodes were clearly seen to become blue and carried compound was sufficient to allow identification with a gamma probe. In conclusion, 99mTc-ISB has the potential to facilitate lymphatic mapping and subsequent sentinel node biopsy for solid malignancies such as breast cancer and melanoma.
Asunto(s)
Ganglios Linfáticos/citología , Ganglios Linfáticos/diagnóstico por imagen , Linfocintigrafia/métodos , Colorantes de Rosanilina/química , Tecnecio/química , Animales , Colorantes/química , Marcaje Isotópico , Radiofármacos/síntesis química , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Sensibilidad y EspecificidadRESUMEN
This study aimed to develop a suitable buccal mucoadhesive nanoparticle (NP) formulation containing fluconazole for the local treatment of oral candidiasis. The suitability of the prepared formulations was assessed by means of particle size (PS), polydispersity index, and zeta potential measurements, morphology analysis, mucoadhesion studies, drug entrapment efficiency (EE), in vitro drug release, and stability studies. Based on the optimum NP formulation, ex vivo drug diffusion and in vitro cytotoxicity studies were performed. Besides, evaluation of the antifungal effect of the optimum formulation was evaluated using agar diffusion method, fungicidal activity-related in vitro release study, and time-dependent fungicidal activity. The effect of the optimum NP formulation on the healing of oral candidiasis was investigated in an animal model, which was employed for the first time in this study. The zeta potential, mucoadhesion, and in vitro drug release studies of various NP formulations revealed that chitosan-coated NP formulation containing EUDRAGIT(®) RS 2.5% had superior properties than other formulations. Concerning the stability study of the selected formulation, the formulation was found to be stable for 6 months. During the ex vivo drug diffusion study, no drug was found in receptor phase, and this is an indication of local effect. The in vitro antifungal activity studies showed the in vitro efficacy of the NP against Candida albicans for an extended period. Also, the formulation had no cytotoxic effect at the tested concentration. For the in vivo experiments, infected rabbits were successfully treated with local administration of the optimum NP formulation once a day. This study has shown that the mucoadhesive NP formulation containing fluconazole is a promising candidate with once-a-day application for the local treatment of oral candidiasis.
Asunto(s)
Antifúngicos/farmacología , Candidiasis Bucal/tratamiento farmacológico , Fluconazol/farmacología , Nanopartículas/administración & dosificación , Administración Oral , Animales , Antifúngicos/administración & dosificación , Antifúngicos/farmacocinética , Células CHO/efectos de los fármacos , Candida albicans/efectos de los fármacos , Bovinos , Quitosano/química , Cricetulus , Sistemas de Liberación de Medicamentos/métodos , Evaluación Preclínica de Medicamentos/métodos , Estabilidad de Medicamentos , Fluconazol/administración & dosificación , Fluconazol/farmacocinética , Masculino , Mucosa Bucal/efectos de los fármacos , Nanopartículas/química , Tamaño de la Partícula , Ácidos Polimetacrílicos/química , ConejosRESUMEN
OBJECTIVES: The aim of the present study was to develop novel ofloxacin (OFX)-loaded nanostructured lipid carrier (NLC)-based inserts for ocular application for treatment of bacterial keratitis. METHODS: NLC loaded with 0.3% OFX was prepared by means of high shear homogenization and 0.75% chitosan oligosaccharide lactate (COL) was added. Glycerin or PEG 400 at the range of 1 - 15% was added to NLCs as plasticizers and inserts were developed by solvent casting evaporation. Characterization, in vitro release, microbiological, ex vivo and in vivo studies were performed. RESULTS: The inserts developed with the addition of glycerin (Ins3OFX) was found as optimal. The kinetic studies revealed that the release of Ins3OFX was a combination of diffusion and swelling. Ins3OFX was more bioadhesive in texture profile analysis studies. In the in vivo studies performed with rabbits, the pre-ocular retention time was enhanced up to 24 h and Cmax was increased almost six times in comparison with commercial. The rabbits were infected with Staphylococcus aureus and keratitis was confirmed. This group was treated with Ins3OFX and they recovered in 7 days with no significant sign of conjunctival redness and corneal opacity. CONCLUSION: NLC-based inserts developed with COL and glycerin may be offered as appropriate vehicles for ocular delivery.
Asunto(s)
Sistemas de Liberación de Medicamentos , Infecciones Bacterianas del Ojo/tratamiento farmacológico , Queratitis/tratamiento farmacológico , Ofloxacino/administración & dosificación , Animales , Disponibilidad Biológica , Córnea/metabolismo , Excipientes/química , Lípidos/química , Nanoestructuras , Polietilenglicoles/química , Conejos , Staphylococcus aureus/efectos de los fármacos , Resultado del TratamientoRESUMEN
Vaginal suppository formulations of metronidazole were prepared using six different bases as Witepsol H15, Cremao, Ovucire WL2944, Ovucire WL3264, PEG 1500, PEG 6000. Three different dissolution methods were used to evaluate the in vitro drug release from the suppositories. The diffusion studies were performed through synthetic (cellophane) and natural membrane (rabbit vagina), but the drug did not show good permeation characteristics from natural membrane. Ovucire WL3264 suppositories of metronidazole labeled with 99mTc (Tecnetium-99m) were used for the vaginal absorption and biodistribution studies in the rabbits. Scintigraphic images were collected after vaginal administration of the labeled suppositories using SPECT gamma fitted with a low energy, high-resolution parallel hole collimator. The labeled drug showed high biodistribution in urine beside vaginal site. The results of this study suggested that the Ovucire WL3264 suppository of metronidazole prepared for vaginal infections could also be effective in the urinary infections.
Asunto(s)
Metronidazol/farmacocinética , Vagina/metabolismo , Administración Intravaginal , Animales , Excipientes , Femenino , Metronidazol/administración & dosificación , Vehículos Farmacéuticos , Polietilenglicoles , Conejos , Solubilidad , Supositorios , Factores de Tiempo , Distribución Tisular , Tomografía Computarizada de Emisión de Fotón Único , TriglicéridosRESUMEN
Extended release liphophilic microspheres of indomethacin were prepared using cetostearyl alcohol (CsA), stearyl alcohol (SA) and cetyl alcohol (CA) in the various drug-lipid ratios. The release of indometacin was studied on the basis of USP criteria and the effects of drug-lipid ratio, the size of microspheres and carboxymethylcellulose sodium (CMC-Na) added as a hydrophilic polymer on the drug release were investigated. In vitro dissolution studies were performed using USP XXIII apparatus I at pH 6.2. Release profiles were evaluated according to first order, Higuchi square root of time and Hixson-Crowell cube root models. The best fit was found with the square root of time model (r2=0.991) for the microspheres (125-250 microm) prepared in 1:4:1 drug-lipid-copolymer ratio using stearyl alcohol. With a further regression analysis, an excellent equation (Release%=-10.721+42.549*square root of (t)-4.027*t) was developed for empirical drug estimation (r2=0.998).
Asunto(s)
Indometacina/química , Indometacina/farmacocinética , Microesferas , Modelos Teóricos , Química Farmacéutica , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinéticaRESUMEN
The purpose of this study is to obtain a drug release at a constant rate with a megaloporous tablet, which was prepared with a simple formulation. These tablets were prepared with two kinds of granules. One of them is the restraining-phase matrix granule (RMG) and it controls the release rate of the drug. The other one is the soluble housing-phase matrix granule (HMG) and controls liquid penetration into the system. Eudragit RL 100 and Eudragit L 100 polymers were used to constitute the restraining and housing matrix phases, respectively. The effect of the amount of Eudragit RL 100 in the RMG was investigated and decreasing of amount of Eudragit RL 100 in the RMG increased the drug release rate. The tablets were prepared with compaction pressures of 188, 377, 1884 and 7540 kg/cm(2) and it was observed that the compaction forces ranging from 377 to 7540 kg/cm(2) did not influence drug release. The effect of the size of the matrices was demonstrated and it was found that the drug release rate increased with decreasing of the size of the tablets. The impact of the dosage to the dissolution rates was also investigated using two different amounts of drug. Therefore, the tablets were designed with two different dosages to use once or twice a day at the dosage interval of every 12 or 24 h, respectively. The release kinetic of the best formulation (4K) of the study was evaluated with the goodness-of-fit analysis and it was seen that the target profile was nearly achieved. This study suggests using megaloporous tablets in therapy, which could be prepared with a simple and cheap way similarly to conventional tablets to obtain a constant drug release.
Asunto(s)
Química Farmacéutica , Antiinflamatorios no Esteroideos/química , Preparaciones de Acción Retardada/química , Diseño de Fármacos , Naproxeno/química , Tamaño de la Partícula , Ácidos Polimetacrílicos/química , Porosidad , Comprimidos/químicaRESUMEN
The objective of this study was to develop a mathematical equation for the calculation of drug release from different shaped matrix tablets. By this way, release rate related to the geometric shape could be predicted with the help of the developed mathematical equation. So, drug release could be estimated before the dissolution. Hydroxypropylmethylcellulose (HPMC) E50 as polymer and theophylline as active substance were used in the matrix tablets prepared for this purpose. Matrix tablets in three different geometrical shapes, namely in triangular, cylindrical and half-spherical forms were prepared by using two different drug-polymer ratio (1:0.5, 1:1) and diluent's in three different percentages (0, 20, 40%). Using rotating paddle and basket methods reported in USP XXIII carried out the release rate studies of these tablets. The Higuchi square-root time model best described the dissolution data. Differential scanning calorimetry (DSC) analysis was performed to identify any solid-state inactivation of the drug. The practical benefit of this work is to improve mathematical equation that can be used to predict accurately the required composition and in order to achieve the desired release profiles of different geometric shaped tablets. By using this equation new pharmaceutical products can be easily improved.
Asunto(s)
Teofilina/análisis , Análisis de Varianza , Rastreo Diferencial de Calorimetría , Interpretación Estadística de Datos , Hidrogeles , Cinética , Reproducibilidad de los Resultados , Solubilidad , ComprimidosRESUMEN
PURPOSE: The aim of this study was to prepare a novel oil-in-water microemulsion of ofloxacin (OFX) for topical ocular application. METHODS: Pseudo-ternary phase diagrams were constructed for combination of oleic acid as oil phase, Tween 80 as surfactant, ethanol as co-surfactant, and 0.5 N NaOH solutions as aqueous phase. The optimum microemulsion was modified with 0.75% chitosan oligosaccharide lactate (COL). The properties of microemulsions in the absence or presence of OFX (0.3%) were measured, such as electrical conductivity, droplet size, viscosity, and pH. The in vitro release study was carried out using the dialysis bag method. Ex vivo permeability studies were performed with rabbit cornea in Franz-diffusion cells. Sterility, minimum inhibition concentration (MIC), and antibacterial activity studies were conducted microbiologically. The preocular residence time and efficacy against bacterial keratitis was compared with a commercial (C) solution via in vivo studies. RESULTS: M2OFX modified with 0.75% COL showed slower release than M1OFX, which does not contain COL. The permeation rate of OFX from M1OFX was significantly higher than M2OFX and the C solution. The formulations were sterile and MIC values were the same for both. M2OFX, which contains 0.75% COL, performed higher antibacterial activity than M1OFX. The preocular residence time was improved by microemulsion in comparison to solution; the addition of COL did not make a significant difference. In total, 8 rabbits gave better results with M1OFX, whereas 4 gave similar scores to commercial solution-applied rabbits. CONCLUSION: In conclusion, OFX microemulsions could be offered as a promising strategy for ocular drug delivery.
Asunto(s)
Córnea/efectos de los fármacos , Emulsiones/administración & dosificación , Ofloxacino/administración & dosificación , Administración Tópica , Animales , Química Farmacéutica/métodos , Quitosano/administración & dosificación , Quitosano/química , Sistemas de Liberación de Medicamentos/métodos , Emulsiones/química , Etanol/administración & dosificación , Etanol/química , Concentración de Iones de Hidrógeno , Masculino , Ofloxacino/química , Ácido Oléico/administración & dosificación , Ácido Oléico/química , Oligosacáridos/administración & dosificación , Oligosacáridos/química , Soluciones Oftálmicas/administración & dosificación , Soluciones Oftálmicas/química , Tamaño de la Partícula , Permeabilidad/efectos de los fármacos , Polisorbatos/administración & dosificación , Polisorbatos/química , Conejos , Hidróxido de Sodio , Tensoactivos/administración & dosificación , Tensoactivos/síntesis química , ViscosidadRESUMEN
The objective of this study was to explore the potential of the nanostructured lipid carriers (NLCs) modified with chitosan oligosaccharide lactate (COL) for topical ocular application. Ofloxacin (OFX) loaded NLCs were prepared by microemulsion or high shear homogenization methods. For combination of NLCs Compritol HD5 ATO was used as solid lipid, oleic acid as liquid lipid, Tween 80 as surfactant, ethanol as co-surfactant. The optimum NLCs was modified with 0.75% COL. The properties of NLCs in the absence or presence of OFX (0.3%) were characterized as zeta potential, particle size, viscosity and pH, TEM, drug loading, encapsulation efficiency and anti-microbial properties. Ex-vivo penetration/permeation studies were performed with rabbit cornea in Franz-diffusion cells. The penetration rate of OFX from NM-COL4OFX and NH-COL4OFX were significantly higher than commercial solution. Based on the selected formulations, in vivo tests were carried out by eye-drop instillation of NLCs in rabbit. The addition of COL improved the preocular residence time, controlled the drug release and enhanced the corneal bioavailability. In conclusion, OFX COL modified NLCs prepared by high shear homogenization method could be offered as a promising strategy for ocular drug delivery.
Asunto(s)
Antibacterianos/farmacología , Portadores de Fármacos/química , Queratitis/tratamiento farmacológico , Lípidos/química , Nanopartículas/química , Ofloxacino/farmacología , Animales , Antibacterianos/química , Quitosano/química , Escherichia coli/efectos de los fármacos , Concentración de Iones de Hidrógeno , Lactatos/química , Masculino , Pruebas de Sensibilidad Microbiana , Ofloxacino/química , Tamaño de la Partícula , Conejos , Staphylococcus aureus/efectos de los fármacos , Propiedades de Superficie , ViscosidadRESUMEN
In this study, a microemulsion system was evaluated for delivery of mitomycin C (MMC). To track the distribution of the formulated drug after intravenous administration, radiochemical labeling and gamma scintigraphy imaging were used. The aim was to evaluate a microemulsion system for intravenous delivery of MMC and to compare its in vivo behavior with that of the MMC solution. For microemulsion formulation, soybean oil was used as the oil phase. Lecithin and Tween 80 were surfactants and ethanol was the cosurfactant. To understand the whole body localization of MMC-loaded microemulsion, MMC was labeled with radioactive technetium and gamma scintigraphy was applied for visualization of drug distribution. Radioactivity in the bladder 30 minutes after injection of the MMC solution was observed, according to static gamma camera images. This shows that urinary excretion of the latter starts very soon. On the other hand, no radioactivity appeared in the urinary bladder during the 90 minutes following the administration of MMC-loaded microemulsion. The unabated radioactivity in the liver during the experiment shows that the localization of microemulsion formulation in the liver is stable. In the light of the foregoing, it is suggested that this microemulsion formulation may be an appropriate carrier system for anticancer agents by intravenous delivery in hepatic cancer chemotherapy.
Asunto(s)
Mitomicina/administración & dosificación , Mitomicina/química , Cintigrafía/métodos , Aceite de Soja/administración & dosificación , Aceite de Soja/química , Administración Intravenosa , Animales , Emulsiones/administración & dosificación , Emulsiones/química , Cámaras gamma , Humanos , Masculino , Mitomicina/farmacocinética , Conejos , Pertecnetato de Sodio Tc 99m/administración & dosificación , Pertecnetato de Sodio Tc 99m/química , Aceite de Soja/farmacocinética , Tensoactivos/administración & dosificación , Tensoactivos/química , Tensoactivos/farmacocinéticaRESUMEN
AIM: To develop a suitable buccal bioadhesive gel formulation containing cyclosporine A solid lipid nanoparticles (CsA SLNs) for the treatment of recurrent aphthous stomatitis. METHODS: The suitability of the prepared formulations for buccal application was assessed by means of rheological studies, textural profile analysis, and ex vivo drug-release studies. Plastic flows, typical gel-like spectra, and suitable mechanical properties were obtained from prepared formulations. The retention time was explored in in vivo distribution studies and the effect of the gel containing CsA SLNs on the healing of oral mucosal ulceration was investigated in an animal model. In vivo distribution studies are a very important indicator of the retention time of formulations at the application site. RESULTS: Distribution studies showed that 64.76% ± 8.35% of the formulation coded "F8+SLN" remained on the buccal mucosa 6 hours after application. For the second part of the in vivo experiments, 36 rabbits were separated into three groups: the first group was treated with the gel formulation without the active agent; the second group with the gel formulation containing CsA SLNs; and the third group, used as the control group, received no treatment. Wound healing was established by scoring of the rate of wound healing on Days 3, 6, 9, and 12. Histological observations were made on the same days as the scoring studies. The bioadhesive gel formulation that included CsA SLNs increased the rate of mucosal repair significantly. CONCLUSION: This study has shown that the bioadhesive gel formulation containing CsA SLNs reported here is a promising candidate for the topical treatment of recurrent aphthous stomatitis.